Mohammad Abu Zaid

2.6k total citations
59 papers, 1.7k citations indexed

About

Mohammad Abu Zaid is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Mohammad Abu Zaid has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 20 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Mohammad Abu Zaid's work include Multiple Myeloma Research and Treatments (12 papers), Testicular diseases and treatments (12 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Mohammad Abu Zaid is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Testicular diseases and treatments (12 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Mohammad Abu Zaid collaborates with scholars based in United States, India and China. Mohammad Abu Zaid's co-authors include Hasan Mukhtar, Farrukh Afaq, Naghma Khan, Deeba N. Syed, Mark L. Dreher, Mohammad Asim, Lawrence H. Einhorn, Sami Sarfaraz, Michal Chovanec and Costantine Albany and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mohammad Abu Zaid

57 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mohammad Abu Zaid

Since Specialization

Citations

This map shows the geographic impact of Mohammad Abu Zaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abu Zaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abu Zaid more than expected).

Fields of papers citing papers by Mohammad Abu Zaid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Abu Zaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abu Zaid. The network helps show where Mohammad Abu Zaid may publish in the future.

Co-authorship network of co-authors of Mohammad Abu Zaid

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Abu Zaid. A scholar is included among the top collaborators of Mohammad Abu Zaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Abu Zaid. Mohammad Abu Zaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-Flow Congenital Arteriovenous Malformation of the Right Deltoid Muscle in a Pediatric Patient: A Case Report 2025 ·Cureus ·Mohammad Abu Zaid, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma 2024 ·Nature Communications ·Travis S. Johnson, Parvathi Sudha, (unknown), (unknown), (unknown), Patrick Blaney, Gareth J. Morgan, Vivek S. Chopra, Cédric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A. Walker	3
3	Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma 2023 ·Blood Cancer Journal ·(unknown), Parvathi Sudha, (unknown), (unknown), Attaya Suvannasankha, Kelvin H. Lee, Rafat Abonour, Mohammad Abu Zaid, Brian A. Walker	6
4	Unraveling Diverse Mechanisms of Complex Structural Variant Interactions through Multiomic Data in Multiple Myeloma 2023 ·Blood ·(unknown), (unknown), Parvathi Sudha, Aneta Mikulášová, Mohammad Abu Zaid, Attaya Suvannasankha, (unknown), Rafat Abonour, Brian A. Walker	2
5	Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT) 2023 ·Clinical Genitourinary Cancer ·(unknown), Rafat Abonour, Mohammad Abu Zaid, Sandra K. Althouse, (unknown), (unknown), Nasser H. Hanna, Nabil Adra, Lawrence H. Einhorn	8
6	Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease 2022 ·Genome Medicine ·Travis S. Johnson, Christina Y. Yu, Zhi Huang, (unknown), Tongxin Wang, Chuanpeng Dong, Wei Shao, Mohammad Abu Zaid, Xiaoqing Huang, (unknown), Christopher W. Bartlett, Yan Zhang, Brian A. Walker, Yunlong Liu, Kun Huang, Jie Zhang	24
7	Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma 2021 ·Oncogene ·Chuanpeng Dong, (unknown), (unknown), Jill L. Reiter, Christina Y. Yu, Yue Wang, Zhaoyang Jiang, Mohammad Abu Zaid, Kun Huang, Xiongbin Lu, Brian A. Walker, Fabiana Perna, Yunlong Liu	25
8	STEPS to Enhance Physical Activity After Hematopoietic Cell Transplantation for Multiple Myeloma 2021 ·Cancer Nursing ·Eileen Danaher Hacker, (unknown), Mohammad Abu Zaid, (unknown), Susan M. Perkins, Sherif S. Farag	10
9	Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors 2021 ·Investigational New Drugs ·(unknown), Darren R. Feldman, Nabil Adra, Mohammad Abu Zaid, Samuel A. Funt, Sandra K. Althouse, Susan M. Perkins, (unknown), (unknown), (unknown), David I. Quinn, Nasser H. Hanna, Lawrence H. Einhorn, Costantine Albany	10
10	Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients 2021 ·Frontiers in Genetics ·(unknown), Mohammad Abu Zaid, Jill L. Reiter, Magdalena Czader, Lin Wang, (unknown), Xiaoling Xuei, Hongyu Gao, Kun Huang, Rafat Abonour, Brian A. Walker, Yunlong Liu	13
11	Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome 2020 ·Bone Marrow Transplantation ·Vaibhav Agrawal, (unknown), (unknown), (unknown), Elizabeth Cox, Robert P. Nelson, Jennifer E. Schwartz, Mohammad Abu Zaid, Rafat Abonour, Michael J. Robertson, Bryan J. Brinda, (unknown), (unknown), Sherif S. Farag	0
12	Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy 2017 ·Publisher ·Chunkit Fung, Howard D. Sesso, AnnaLynn M. Williams, Sarah L. Kerns, Patrick O. Monahan, Mohammad Abu Zaid, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Christian Kollmannsberger, Ryan Cook, Sandra K. Althouse, Shirin Ardeshir‐Rouhani‐Fard, (unknown), Lawrence H. Einhorn, Sophie D. Fosså, Lois B. Travis	1
13	Long-term toxicity of cisplatin in germ-cell tumor survivors 2017 ·Annals of Oncology ·Michal Chovanec, Mohammad Abu Zaid, (unknown), (unknown), Lawrence H. Einhorn, Costantine Albany	142
14	Biomarker Panel for Chronic Graft-Versus-Host Disease 2016 ·Journal of Clinical Oncology ·Jeffrey Yu, Barry E. Storer, Kushi Kushekhar, Mohammad Abu Zaid, Qing Zhang, Philip R. Gafken, Yuko Ogata, Paul J. Martin, Mary E.D. Flowers, John A. Hansen, Mukta Arora, Corey Cutler, Madan Jagasia, Joseph Pidala, Betty K. Hamilton, George L. Chen, Iskra Pusic, Stephanie J. Lee, Sophie Paczesny	89
15	Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring 2015 ·Analytical and Bioanalytical Chemistry ·Jiangjiang Zhu, Danijel Djukovic, Lingli Deng, Haiwei Gu, Farhan Himmati, Mohammad Abu Zaid, E. Gabriela Chiorean, Daniel Raftery	59
16	Protective effect of pomegranate‐derived products on UVB‐mediated damage in human reconstituted skin 2009 ·Experimental Dermatology ·Farrukh Afaq, Mohammad Abu Zaid, Naghma Khan, Mark L. Dreher, Hasan Mukhtar	155
17	Inhibitory effect of oral feeding of pomegranate fruit extract on UVB-induced skin carcinogenesis in SKH-1 hairless mice 2008 ·Cancer Research ·Farrukh Afaq, Mohammad Abu Zaid, Naghma Khan, Deeba N. Syed, (unknown), Sami Sarfaraz, Yewseok Suh, Hasan Mukhtar	4
18	Exposure of normal human epidermal keratinocytes to ozone results in increased expression of cytochrome P450 through activation of aryl hydrocarbon receptor 2008 ·Cancer Research ·Mohammad Abu Zaid, Farrukh Afaq, Naghma Khan, (unknown), Mary S. Matsui, Daniel Maes, Hasan Mukhtar	1
19	Inhibition of UVB‐mediated Oxidative Stress and Markers of Photoaging in Immortalized HaCaT Keratinocytes by Pomegranate Polyphenol Extract POMx 2007 ·Photochemistry and Photobiology ·Mohammad Abu Zaid, Farrukh Afaq, Deeba N. Syed, Mark L. Dreher, Hasan Mukhtar	95
20	Delphinidin, an Anthocyanidin in Pigmented Fruits and Vegetables, Protects Human HaCaT Keratinocytes and Mouse Skin Against UVB-Mediated Oxidative Stress and Apoptosis 2006 ·Journal of Investigative Dermatology ·Farrukh Afaq, Deeba N. Syed, Arshi Malik, Naghma Hadi, Sami Sarfaraz, Mee‐Hyang Kweon, Naghma Khan, Mohammad Abu Zaid, Hasan Mukhtar	193

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact